Mark Sheptoff Financial Planning, LLC Vertex Pharmaceuticals Inc Transaction History
Mark Sheptoff Financial Planning, LLC
- $180 Million
- Q2 2025
A detailed history of Mark Sheptoff Financial Planning, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Mark Sheptoff Financial Planning, LLC holds 10,771 shares of VRTX stock, worth $4.24 Million. This represents 2.66% of its overall portfolio holdings.
Number of Shares
10,771
Previous 10,671
0.94%
Holding current value
$4.24 Million
Previous $5.17 Million
7.31%
% of portfolio
2.66%
Previous 2.92%
Shares
29 transactions
Others Institutions Holding VRTX
# of Institutions
1,810Shares Held
239MCall Options Held
1.95MPut Options Held
1.14M-
Capital World Investors Los Angeles, CA28.7MShares$11.3 Billion1.94% of portfolio
-
Vanguard Group Inc Valley Forge, PA24MShares$9.43 Billion0.18% of portfolio
-
Black Rock Inc. New York, NY21.3MShares$8.38 Billion0.23% of portfolio
-
Capital Research Global Investors Los Angeles, CA16.1MShares$6.33 Billion1.5% of portfolio
-
State Street Corp Boston, MA11.8MShares$4.63 Billion0.2% of portfolio
About VERTEX PHARMACEUTICALS INC
- Ticker VRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 256,691,008
- Market Cap $101B
- Description
- Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...